Tag: MSD introduces new drug treatment for lung cancer in Malaysia

MSD introduces new drug treatment for lung cancer in Malaysia

August 29, 2019

Lung cancer is responsible for about 1.76 million deaths globally and is the third most common cancer in Malaysia, from 2007 to 2011. There are two major types of lung cancer, non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) – the former accounts for more lung cancer cases than the latter. As […]

Continue Reading